Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 10 | 1 | 48 | |
Groupe AEF [Automatic translation follows] Digital professional press group and event organizer. All economic sectors are currently experiencing profound economic, legal, legal and regulatory changes. In this unstable context, where the cycle of changes has accelerated, access to precise, reliable and neutral daily information is essential. It is the job of Groupe AEF to inform managers and executives. Information agencies, professional magazines and events (trade fairs, meetings, clubs) allow everyone to access essential information and make useful contacts. AEF Group is made up of 5 specialized information centers: AEF Education-Research: education, higher education, research and innovation, curriculum and integration, AEF Social-HR: professional … Type: Media | 171 | 53 | 114 | 163 | |
Arkhn [Automatic translation follows] We help hospitals manage and leverage their data. 📣 We're hiring! Arkhn gives healthcare institutions back sovereignty over their data, to better support patients, facilitate the work of caregivers and accelerate research. Created in 2019, Arkhn supports healthcare institutions in managing their data sustainably thanks to an interoperable data architecture that is deployed within the centers. This architecture makes it possible to aggregate, qualityize and standardize all health data and facilitate access to it, in order to simplify patient care for medical teams. More broadly, it also promotes clinical research and health innovation, by offering effective and … Type: Startup Activities: it services healthtech Technologies: Data Analytics | 40 | 8 | 28 | 34 | |
RESOLUTION Spectra Systems Leader in advanced optical spectroscopy with solutions dedicated to bioprocess Raman monitoring & laser characterization Leader in bioprocess analytical monitoring, RESOLUTION Spectra Systems is now part of Merck PAT, Raman spectroscopy, Chemometrics, Bioprocess, Bioprocess analytics, Cell culture monitoring, Upstream process development monitoring, Process Analytical Technology, Downstream processes control, In-line monitoring, and Real-time monitoring Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 8 | 2 | 8 | 3 | |
GeodAIsics Responsible AI for Healthcare We develop Clinical Decision Support Systems in all medical fields based on Responsible Artificial Intelligence. Type: Startup Activities: healthtech Technologies: A.I. | 5 | 5 | 0 | 14 | |
ANTINEO Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 4 | 12 | |
Defymed Advanced therapies inspired for you Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort. Defymed is a spin-off of the Centre européen d’étude du Diabète (European center for diabetes studies), which began work on a bioartificial pancreas in 1996. Today, Defymed focuses on diabetes, which is considered to be one of the major epidemics of the 21st century. There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase: - #MailPan®: bioartificial … Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 28 | 7 | 24 | 3 | |
ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 2 | 8 | |
CELLforCURE by Seqens Trustworthy development and commercial manufacturing of CELL&GENE therapies On december 1st 2023, Seqens completed the acquisition of CELLforCURE. Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities. Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle. CELLforCURE teams aim at partnering … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 4 | 2 | 2 | 57 | |
Molsid Time is Life. We develop life saving AMR diagnostics that are fast and reliable. Innovative BioMed company, developing a new generation of fluorogenic molecular probes, for applications such as rapid medical diagnostics, drug discovery and medical imaging, but also food quality control. Based on over 15 years of R&D at the prestigious ENS University de Lyon, Molsid’s patented SmartID technology is considered a breakthrough in high quality identification of enzyme activity in live cells. Molsid offers the broadest range of robust fluorogenic precipitation-based probes available on the market. We offer unsurpassed fast and sensitive fluorescence detection for a large panel … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 3 | 5 | 16 | |
Meanwhile SAS [Automatic translation follows] Mobile Robot Designer: Innovation only takes place on the condition that it is at the service of Being... Share Capital €288,337 HISTORY Meanwhile SAS is a French company created in December 2017 by 7 shareholders sharing a common vision. Meanwhile, specialized in Robotics-Automation-Computer Science, offers "For Human" solutions: It is no longer possible, in today's world, to offer "Humanless" systems without taking into consideration Women, Men, their experiences, their know-how, all the value that They and They represent within the company. They and They are the history of all professional activities and will be the future, undeniably. … Type: Startup Activities: it services Technologies: Robotics A.I. | 27 | 12 | 23 | 19 | |
Luxia Scientific New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, … Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology | 4 | 3 | 0 | 1 | |
NH TherAguix Nanomedicine For Precision Radiotherapy NH TherAguix , a Phase 2 biotech company, has developed an innovative nano drug AGuIX® to improve cancer treatment by radiotherapy to treat tumours and metastases. Its pharmacological properties and its mode of action by bio-distribution allow it to act in the heart of tumors and confer it a pan-cancer potential. AGuIX® is currently assessed in 4 Phase II randomized trials in brain metastases using either whole brain radiation therapy (NANORAD2, CHUGA, Grenoble, France) or stereo-radiosurgery (NANOBRAINMETS, Dana Farber Brigham Cancer Center, Boston, USA), in glioblastoma (NANOGBM, multicentric, Clermont Ferrand, France) as well as in pancreatic … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 8 | 7 | 1 | 21 | |
ErVimmune Targeting shared unconventional tumor antigens in cancer immunotherapy R&D oncology | 7 | 3 | 5 | 18 | |
Extremis Robotics Robotic solution for precise and repeatable foot surgery Extremis Robotics is a startup company specializing in research and development of a medical device in the field of surgical robotics of the foot. Our aim is to provide foot surgeons a precise and repeatable surgical procedure using innovative technologies in tracking systems and robotics. The team at Extremis Robotics is highly skilled in surgical robotics, navigation and foot surgery. Type: Startup Activities: healthtech Technologies: Robotics | 2 | 2 | 0 | 7 | |
PK MED Tailor-designed drug implants for local treatments. Founded by Truffle Capital. PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a European Venture Capital firm specializing in Life sciences. PK MED was created around a small team of passionate and experienced experts in pharmaceutical and medical sciences, drug delivery and biomaterials design. PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes. The … Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 10 | |
Ekno [Automatic translation follows] EKNO supports business and institutional leaders at the crossroads of their Identity, Strategy, Management and Communication challenges. A corporate communications consulting agency, EKNO offers its clients an enriched value chain and extensive intervention registers structured around strategic consulting, content creation and event production. Our team operates in 3 areas of expertise that reconcile long-term (projection and vision) and short-term (daily life and contingencies) 1 / Revealing the fundamentals of identity 2 / Marking out strategic projects 3 / Dialogue with stakeholders. As companions of management teams, EKNO consultants intend to challenge them, confront them with new sources … Type: Startup Activities: consulting Technologies: SaaS | 18 | 6 | 14 | 49 | |
HawkCell Shaping the future of healthcare, one image at a time. We are HawkCell, and we act now. We're on a mission to make the healthcare industry more efficient and sustainable. We do this one animal MRI image at a time with a patented plug-and-play solution turning human MRI into an animal-dedicated one for veterinary clinics and preclinical research labs. We're a young company, but we're well on our way to becoming the undisputed leader in animal imaging. After consolidating our presence in Europe, we have the ambition to expand rapidly to the United States and Asia and become the undisputed … Type: Startup Activities: pettech healthtech deeptech Technologies: A.I. | 15 | 7 | 4 | 27 | |
Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 9 | 10 | 35 | |
MEERSENS Environmental intelligence for smart decisions. Mitigate environmental risks & positively contribute to health/wellbeing Meersens - certified #GreenTech & #DeepTech - is a positively impactful company in the field of environmental health (☁️ air, 💧water, 📣 noise, 🌻 pollen, 🔥 fire, 🌦️ weather, ☀️UV...). Our mission: to build a sustainable future by mitigating environmental risks and promoting the well-being of all stakeholders - by offering personalized environmental monitoring and prevention. Thanks to our cutting-edge tools (SaaS, API, IoT, App), you benefit from 360°, real-time, historical, and predictive information on a multitude of pollutants, for any location. This high precision data enables … Type: Startup Activities: cleantech healthtech biotech deeptech greentech Technologies: A.I. - Machine Learning A.I. IoT Sensors | 73 | 16 | 69 | 12 | |
CTIBiotech Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 19 | 2 | 15 | 22 | |
Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 1 | |
Pomega Laboratories New Natural & Ethical Anti Inflammatory Pharmaceutical Products Natural Products with Proven Health Claims For PETS. Pomega develops a novel, safe, ethical and non-toxic therapy that retards disease progression by inhibiting cartilage breakdown at an earlier stage. Product is developed by skilled pharmacist under drug standards frame First product coming out the pipeline is Ω-344 Product , a patented fruit extract with strong anti inflammatory properties osteoarthritis , anti inflammatory, fruit extract, inflammation, arthritis, biotech, NSAIDs, pain, animal, dogs, pets, wellness, healthcare, petfood, and cats Type: Startup Activities: pettech deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | N/A | |
Sirius NeoSight [Automatic translation follows] New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company whose ambition is to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic efficacy implemented. Sirius NeoSight uses a patented breakthrough technology from a consortium of academic laboratories that are experts in the field. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 17 | 6 | 6 | 4 | |
HEPHAISTOS-Pharma [Automatic translation follows] Developing the weapons that we need to defeat cancer. HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies to revolutionize cancer treatments by increasing the effectiveness of monoclonal antibodies and allowing the treatment of incurable tumors. Oncology, immunotherapy, and cancer | 23 | 11 | 6 | 11 | |
GAPSMOOV - Le décodeur de cultures [Automatic translation follows] The digital learning specialist in intercultural management. Gapsmoov is the inventor of the "Culture Decoder": a digital learning platform in intercultural management. By focusing on micro-learning, impactful videos and virtual classes, we help employees of global companies and students to decode the cultural behaviors of their foreign interlocutors so that they become more efficient on a daily basis. Negotiating with the Chinese, conducting a meeting with Americans, giving a presentation to Indians... in total, more than 90 business situations are deciphered in an ultra-pragmatic, fun... and addictive way! ; ) Why do our customers choose Gapsmoov? It … | 5 | 2 | 1 | 4 | |
SYNTHELIS Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 5 | 12 | 9 | |
Vidium Solutions Data analysis and in silico modelization solutions for genetic research and personalized medicine Expert in systems biology, VIDIUM brings data analysis and in silico modelization solutions for genetic research. We unlock the power of single-cell analysis to characterize and master the complexity of cell fate dynamics: "As Google did for urban networks, we built our navigation map in cellular genetic networks!" Guided by knowledge-driven approaches, we create highly representative digital twins from single-cell data, to make accurate predictions. These in silico avatars of genetic networks allows us to "find our way" through the billions of possible interactions between our 20,000 … Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 5 | 0 | 4 | 8 | |
WHYN [Automatic translation follows] At the heart of your industrial strategy. WHYN, at the heart of your industrial strategy. Whyn allows you to decide on your industrial strategy and make the industry of the future accessible to industrial SMEs via tools, methods and specific know-how: 1-Modernize the production tool and your business processes. WHYN relies on an ecosystem, expertise and field experience. 2-Size Human and Industrial resources. WHYN uses tools such as diagnostics and relies on its ecosystem. 3-Raise competitiveness standards. WHYN uses the tools of the industry of the future, operational excellence and Lean management. The benefits for the supported … Type: Startup Activities: industry 4.0 | 21 | 1 | 21 | 3 | |
FasTeesH [Automatic translation follows] HesY, a medical device for effective dental brushing in 10 seconds for healthcare and accommodation establishments 📢📢📢Our consumer product, Y-Brush, is available now: http://ow.ly/DMal30luqQK 🚀🚀🚀 FasTeesH is a Lyon startup developing a "toothbrush of the future" that cleans all teeth simultaneously, simply and effectively, in just 10 seconds. Why? Few people like brushing their teeth. This daily task is therefore often "badly" and/or "quickly" done. This can lead to health problems, sometimes very serious. How? Currently, we brush only 1 side of 1 tooth at a time. Our innovation allows us to brush 16 complete teeth simultaneously … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 0 | 2 | |
Spine Innovations PRESERVING SPINE MOTION Spine Innovations, the new spine independent company, went live in 2020 despite the sanitary situation. The main spine products are the ESP disc prostheses which have the particularity of being designed monobloc and viscoelastic. The monobloc design allows the ESP disc replacements to be implanted as easily as stand-alone cages. The instruments associated to the ESP disc replacements, are simple, easy and reliable as the feedback received from most users. For more information about Spine Innovations please visit www.spine-innovations.com, for more information on the devices please visit www.esp-disc.com. Type: Startup Activities: it services manufacturing | 1 | 1 | 0 | 9 | |
Innovapeek [Automatic translation follows] Innovapeek is a French start-up specializing in the development and marketing of innovative medical instruments and services. We are developing a unique connected traceability system dedicated to medical instruments. We have also developed a range of innovative pliers for orthodontists. They incorporate our traceability system and are 100% manufactured in France with 2.0 industrial processes such as 3D Metal printing. We have around ten practitioners in our capital and are supported by the BPI and the Rhône Alpes region. Type: Startup Activities: deeptech healthtech manufacturing | 2 | 1 | 2 | 2 | |
Kejako Keep your Eyes Young Our mission Kejako, in the field of ophthalmology, merge Medtech and Engineering expertise to develop solution for interested presbyopic patients seeking to keep quality of life through the compensation of visual accommodation decay. We address presbyopia with an anti-aging mindset to treat the gradual loss of visual accommodation. Our promise, unlike any other existing surgical solution, is to provide non-invasive (ultra-minimally invasive or a “no-cut”) laser solution to delay the need for reading glasses without compromising the patient’s quality of vision. Our solution will be fully personalized to the patient by using our simulation expertise which … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 2 | 4 | 6 | |
ECHODIA ECHODIA offers a wide range of devices specifically adapted to ENT doctors and other healthcare professsionals ECHODIA is a company created in 2009 specialized in hearing assessment in the fields of otorhinolaryngology and neuroscience. It develops and markets several devices dedicated to auditory measurements, specifically adapted to ENT doctors and other healthcare professionals’ needs (hearing care professionals, school nurses, occupational doctors, hospitals, etc.). ECHODIA offers a wide range of screening and diagnostic devices made in France so that you can perform all your hearing tests. ENT, HEARING, MEDICAL DEVICES, OCCUPATION HEALTH, SCREENING, AUDIOMETRY, ABR, TEOAE, MENIERE DISEASE, OCCUPATIONAL MEDICINE, OTOACOUSTICS … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 6 | |
3-D Matrix EMEA 3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 49 | |
Biothelis [Automatic translation follows] Predicting respiratory distress BIOTHELIS develops and markets the ENDOMARK H1A medical device to predict the occurrence of severe respiratory distress in patients admitted to intensive care. Applicable to COVID-19 pneumonia, it optimizes patient care and improves prognosis. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 2 | |
PREVIA MEDICAL Artificial Intelligence detecting patients complication risks, compatible with all major EHR systems with FHIR PREVIA is an artificial intelligence capable of forecasting pathologies. Compatible with all major EHR systems using FHIR technology, it analyzes the data of thousands of patients in real time and accurately identifies the complications risks. The first score SEPSI-SCORE, MD certified in 2021, alerts up to 48 hours before the first symptoms of sepsis. Health care professionals can trigger treatment protocols earlier, reducing lengths of stay and saving lives. AI, FHIR, HEALTHCARE, MACHINE LEARNING, ESANTE, Medecine predictive, SEPSIS, and INNOVATION Type: Startup Activities: healthtech Technologies: A.I. A.I. - Machine Learning | 18 | 3 | 16 | 9 | |
ORPHELIA Pharma Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 10 | |
BIOMNIGENE Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 3 | 2 | 7 | |
Lumeen [Automatic translation follows] Social and therapeutic virtual reality. Created by two brothers who wanted to offer moments of escape to their grandmother, Lumeen aims to bring the social and therapeutic benefits of virtual reality to as many people as possible. We design a medical device used to act against anxiety, pain and to reduce medication consumption. It finds its place in many fields such as surgery, oncology, palliative care, disability, etc. In geriatrics, it is also used to improve well-being, promote social ties, revive memory and reduce behavioral disorders. Evaluating the impact of our solution is important to us and … Type: Startup Activities: silvertech healthtech Technologies: VR | 17 | 7 | 13 | 17 | |
LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 7 | 7 | 1 | 11 | |
Carthera Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 31 | 11 | 20 | 29 | |
baio-dx Artificial Intelligence for Digital Microbiology With its unique solutions for clinical and industrial microbiology based on artificial intelligence and holographic images, BAIO-DX aims at becoming a leader in holographic digital microbiology. WHO states "antimicrobial resistance (AMR) is a global health and development threat". BAIO-DX provide diagnostic solutions for microbiological laboratories to reduce the time to results. The combination of lensless holographic imaging technology and Artificial Intelligence algorithms allows an unique, large-field observation of biological objects at microns scale. Identification of pathogens and reading of antibiotic susceptibility testing (AST) will be carried out automatically, directly on agar plates in only few … Type: Startup Activities: healthtech it services Technologies: A.I. | 12 | 1 | 12 | 11 | |
COCONT [Automatic translation follows] Fast and unique turnkey plant production Company specializing in the development and production of fermented or non-fermented plant alternatives with high nutritional value. | 5 | 3 | 0 | 4 | |
StromaCare Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb for the treatment of cancers StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France. oncology and monoclonal antibody Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 | 2 | 16 | |
Neolys Diagnostics En cancérologie, la médecine personnalisée n’est plus une option. Neolys was born out of a common interest between industry and radiobiology researchers from Lyon, France to meet a particular need: predicting radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities. Neolys thus developed a reliable technology based on predictive tests, allowing for patient-specific treatments. Our solutions both optimize radiotherapy treatments efficiency and toxicity prevention. Neolys Diagnostics joined ALARA Group in late 2019. Radiation Oncology, Radiosensitivity, Precision Medicine, Médecine personnalisée, Radiosensibilité, and Radiothérapie Type: Startup Activities: healthtech biotech deeptech | 13 | 6 | 6 | 7 | |
Microlight3D The world's highest resolution 3D-printers for all your micro/nano applications The world's highest resolution (up to 0,1 micron) 3D-printers for all your micro/nano applications. Microlight3D is a specialty manufacturer of ultra high-resolution 3D-printers for industrial and scientific applications. It enables customers with new development needs to produce the most demanding precision micro parts with the smoothest surfaces. The company’s two-photon polymerization technology, which includes proprietary software tuned for increasingly faster direct laser writing speeds with sub-micron resolution, is compatible with the widest range of polymers and biological materials. Sold worldwide, Microlight3D’s microprinting machines produce ready-to-deploy 3D structures in any geometric … Type: Startup Activities: biotech deeptech industry 4.0 manufacturing Technologies: 3D Printing New Materials Robotics | 19 | 7 | 7 | 20 | |
Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 11 | 3 | 4 | |
Beams Detecting Cancer, Expanding Life Accuracy of tumor resection is essential for solid tumors treatment. Beams develops an intraoperative probe (called TRIOP) dedicated to helping surgeons localising precisely and in real time tumor residues and removing them while preserving surrounding sound tissues. Intended for heath facilities with a nuclear medicine department, this probe aims to better preserve the patients' quality of life. Because its working principle is based on β particles detection, TRIOP is independent from the cancer type. Futhermore, it can be coupled to an excision tool or a suction device, adding them a new functionality and turning them into … Type: Startup Activities: deeptech manufacturing | 16 | 8 | 13 | 6 | |
ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 6 | 6 | 34 | |
MEXBRAIN [Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of extracting metals specifically, quickly and in a controlled manner. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation Type: Startup Activities: nanotech biotech deeptech healthtech Technologies: Synthetic Biology | 12 | 2 | 3 | 13 | |
Polypus [Automatic translation follows] Scale-up your business Dive into the world of Polypus! Whether you are the manager of a small or large company, looking to accelerate or transform your activities, Polypus is at your side. We offer personalized support and in-depth expertise in key areas of development. Propel your business to new heights! We offer comprehensive support, from strategy to implementation, in order to solve the challenges faced by managers. Our approach is distinguished by its innovative and pragmatic nature, moving away from traditional consulting methods. Request your acceleration diagnosis to discover our method. Strategic marketing, Business development, Business plan, … | 41 | 4 | 38 | 10 | |
Buzz E-santé [Automatic translation follows] Digital is not a revolution but an awareness! Information media on digital health. E-health, telemedicine, web health, m-health, connected health... will no longer hold any secrets for you! digital, e-health, telemedicine, digtal pharma, and connected health Type: Media Startup Activities: healthtech | 67 | 7 | 64 | 1 | |
Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 4 | 9 | 8 | |
INOVOTION Which molecule will stand out INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 17 | 7 | 11 | 19 | |
NMR - Bio Your partner for innovation NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation). Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 2 | |
Effidence Optimize your logistics flows with our collaborative and autonomous handling AMR. Effidence is a French company that designs autonomous mobile robots to optimize flows on all types of support and meet the current challenges of the logistics and industrial supply chain. Founded in 2009, our agile and efficient robotic solutions fit your needs and your growth: they can be used as collaborative robots in "follow-me" mode and autonomously to work with or near humans. Our range of AMR covers all types of applications with the : EffiBOT, multitask AMR indoor outdoor EffiBOT-XS, agile and compact AMR EffiBOT-P, hybrid robotized stacker … Type: Startup Activities: transporttech industry 4.0 manufacturing Technologies: Robotics | 37 | 11 | 33 | 16 | |
Doct'up [Automatic translation follows] Doct'up: The mobile application for supporting and coordinating the orthopedic care pathway. Perioperative care, the revolution is on its way! ▹ Because the success of surgical procedures goes beyond the operating room, ▹ Because patients often lack involvement in their rehabilitation, ▹ Because communication difficulties between surgeons and physiotherapists persist, ▹ Because access to physiotherapy is complex due to medical deserts or the overload of patient requests, We have thus developed an e-health solution, in close collaboration with surgeons and physiotherapists, which makes it possible to respond to these challenges. Our approach aims to complement, rather than … Type: Startup Activities: healthtech | 1 | 1 | 0 | 10 | |
Institut Carnot CALYM Consortium dedicated to partnership-based research on lymphomas CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere. CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research: 2 non-profit associations: – The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of … Type: NGO, Think-tanks, Ed, & Culture Startup Activities: deeptech Technologies: Synthetic Biology | 23 | 2 | 23 | 24 | |
POXEL Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 26 | |
NOODDIS NOODDIS manufactures automated dispensing systems for nominative liquid single doses for hospital pharmacies. NOODDIS designs and manufactures automated dispensing systems for hospital pharmacies. Experts in dosing, traceability, packaging and heat sealing, the NOODDIS teams have been innovating for several years to meet the specific needs of pharmacists. With the scientific support of PDA experts for over 5 years, NOODDIS is now launching the ADP-20L, the second generation of automated dispensing systems for oral medications. NOODDIS has opted for 100% French products and favours responsible, local purchasing. dosage, thermoscellage, automate, PDA, iatrogene, pharmacie, hopital, pharmacien, ADP20L, and dispensation Type: Startup Activities: healthtech manufacturing Technologies: Robotics | 3 | 2 | 0 | 6 | |
Gencovery Democratize AI and data to accelerate innovation in biotechnology using the full digital ecosystem ConstellabTM Gencovery is a leading software company specialized in the digitization of complex R&D projects in biotechnology and in the pharmaceutical industry. We have developed the game-changing digital platform ConstellabTM, which is a full digital ecosystem enabling the end-to-end digitization of R&D value chains to streamline, and sustainably accelerate processes • Data & computing infrastructures, • Traceability of data and projects • Management of teams and knowledge, • Bioinformatics and artificial intelligence, • Digital twins of cellular metabolism, • Structured omics databases. Biotechnology, Digital twins, Digital … Type: Startup Activities: biotech deeptech it services Technologies: SaaS A.I. | 28 | 4 | 16 | 10 | |
Brenus Pharma New generation of precision medicine in oncology with proprietary STC platform designed to generate cancer-vaccines 🧬🟣 We are building a company with a bold ambition to become a leader in cancer vaccines, making patients active participants in their own fight against cancer. Cancer is an evolving target that constantly adapts to escape the immune system and resist to treatment. Given this high unmet need, we developed a tech-platform generating new therapeutic vaccines against cancer, called STC for ‘Stimulated-Tumor-(ghost)-Cells’. STC mimics, in the laboratory, the relapse conditions of patients' tumor cells to educate their immune systems to be able to anticipate, … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 26 | 9 | 13 | 18 | |
SGH Medical Pharma Your pharmaceutical industry’s partner, from OEM subcontracting to the design & manufacture of injected medical devices. SGH Medical Pharma results from the alliance of 3 plastic processing companies with a solid reputation of 30 years of know-how (Rovipharm, Eskiss, Stiplastics). The different facilities are certified ISO 13485, including clean rooms The SGH Medical Pharma group designs and produces innovative solutions for : - Drug and supplement administration for solid and liquid medicines : dosing syringes, measuring cups and spoons, single doses, pipettes for droppers and pill dispensers... - Pharmaceutical use : plunger for pre-filled syringes, pre-filled syringes... - IV diagnostics … Type: SMB Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 4 | 1 | 4 | 106 | |
Medimprint Tissue fingerprinting as an innovation to better diagnose and treat brain diseases Medimprint develops innovative, non-lesion medical devices, for clinical research in brain tumors and neurodegenerative diseases. Based on a new concept, “the brain tissue imprint”, Medimprint’s products are the new generation of companion medical devices for personalized and targeted therapies. The non-lesion feature of this concept allows an exclusive in vivo access to : - Tumor heterogeneity - Peritumoral regions - Neurodegenerative regions for poly-omic molecular analyses. Medimprint’s technology breakthrough relies on the integration of functionalized silicon chips to surgical stylet for atraumatic sampling. Through an original « hide … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 1 | 7 | 5 | |
Sinnovial SAS [Automatic translation follows] Sinnotest® supports rheumatologists in optimizing the prescription of biotherapies in rheumatology SINNOVIAL is a biotechnology company that develops personalized medicine devices to improve the management of Chronic Inflammatory Rheumatism (CIR) in Rheumatology (rheumatoid arthritis, ankylosing spondylitis, in particular). Our mission: to improve the quality of life of patients by maximizing the chances of success of their treatment with biotherapy. Our goal: to provide the doctor with a device to help with therapeutic orientation that allows him, in real time, to optimize the selection of biotherapy. "The right treatment, for the right patient, at the right time!" Biotechnology, … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 3 | 4 | |
Twinsight Digital Twins for biomechanical analysis in orthopedics surgery TwInsight offers an online biomechanical modeling and simulation ecosystem providing access to personalized digital twins. Our models are based on a body of validated functional and structural anatomy. The Twinsight platform is made available to healthcare professionals as well as medical device industry such as manufacturers of implants, orthotics and insoles in order to: • support better surgical outcomes through surgical planning optimization on an accurate digital twin of the patients created automatically from medical images and/or surfacic 3D scan, • support better design of medical devices through in silico studies on … Type: Startup Activities: healthtech Technologies: SaaS | 31 | 10 | 6 | 12 | |
Cellenion Experts in single cell isolation technology for sequencing and cell line development applications. Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 25 | |
NeoVirTech Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. The company has been highlighted in the Top10 drug discovery companies, Europe, 2019 by the PharmaTechOutlook Magazine. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging. At NeoVirTech, we believe everyone can have access to state-of-the-art virology techniques. We are focusing our activities on antiviral discovery, study of oncolytic and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 2 | 6 | 6 | |
AUROBAC THERAPEUTICS Developing precision medicines to combat bacterial infections, AMR, and their consequences in acute care settings. AUROBAC THERAPEUTICS is a biopharmaceutical company founded in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to develop the next generation of precision medicines to combat bacterial infections, Antimicrobial Resistance (AMR), and their consequences in acute care settings. AUROBAC’s R&D strategy addresses these unmet medical needs with patient- and pathogen-targeted programs designed to tackle both the causes and consequences of potentially life-threatening bacterial infections and AMR, including hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) and sepsis. Central to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 3 | 23 | |
NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 30 | 10 | 25 | 38 | |
Osivax Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company … Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 23 | 11 | 15 | 52 | |
KEYROS MEDICA (ex REVINAX) Medical Knowledge Broadcast Keyros Medica, the comprehensive paramedical & medico-surgical encyclopedia that enhances your professional expertise. Keyros Medica is the premier multidisciplinary encyclopedia of immersive tutorials, designed specifically for Healthcare Professionals (surgeons, nurses care assistants, medical & paramedical students). Available through our intuitive app and online platform, Keyros Medica provides a wealth of resources to enhance your technical practice. Share insights, watch detailed tutorials, simulate procedures, and train with our extensive, on-demand content. Whether you’re in the classroom, the clinic, or on the go, Keyros Medica ensures you have access to the training you need, whenever and wherever you want. … | 38 | 3 | 35 | 12 | |
EYE TECH CARE Ultrasound Cyclo Plasty = Focused, Adaptable, Proven EYE TECH CARE, based in Lyon, was founded in 2008 by experts in the field of therapeutic ultrasound. The company develops and markets medical devices for the non invasive treatment of eye diseases. Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization). With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 3 | 0 | 24 | |
Superwyze Superwyze : unique solution for controlling and managing equipment, energy flows and patients in the healthcare sector. Vos flux (équipements, énergie, consommables,...) sur votre écran, comme si vous y étiez, et en live !!! Superwyze est une solution de pilotage et de gestion des équipements, des flux énergétiques et des patients dans le secteur de la santé. Simple d’utilisation et intuitive, notre solution répond parfaitement à vos besoins. Superwyze connecte vos équipements via des micro capteurs dont les signaux sont interprétés par un algorithme puissant de positionnement et de suivi d’activité. Notre Promesse : Assurer en permanence la réponse adaptée … Type: Startup Activities: cleantech greentech Technologies: IoT | 10 | 6 | 7 | 9 | |
Valneva Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. … Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology | 24 | 11 | 6 | 654 | |
Olgram marine-inspired molecules to fight immunological diseases Olgram is a biotechnology company developing first-in-class, proprietary immunotherapies to treat immune deficiencies, beginning with immuno-depression after traumatic brain injury and concussion. Biotechnologie, immunologie, antibiorésistance, and commotions | 4 | 4 | 0 | 6 | |
Huggy, le Recrutement Circulaire [Automatic translation follows] Discover the power of Circular Recruitment to accelerate great professional encounters Huggy's mission? Help companies, organizations and candidates move from linear recruitment to circular recruitment! Huggy allows employer communities to share their recommendations on candidates to source the right profiles more easily and quickly... and for candidates to bounce back faster in their search! #sharingiscaring #circularrecruitment #CSR Recruitment, Circular recruitment, CSR, and Employer brand | 34 | 3 | 31 | 10 | |
O-Kidia Transdiagnostic, tech, et IA éthique pour réduire l'errance médicale et accélérer la prise en charge en Santé Mentale The startup O-Kidia develops software applications for health professionals to support diagnosis and right care in children and adolescents with neurodevelopmental and related mental disorders. We combine cutting-edge machine learning and biometry to identify digital biomarkers that will facilitate diagnosis and therapeutic decision making of neurodevelopmental and related mental disorders for health professionals. Our digital tools measure contactless, by a simple 30-minutes video, mental-related parameters: attention, social, anxiety, emotional, behavioral, motricity, visual speed, sleep variables to support diagnosis and therapeutic decision making … Type: Startup Activities: kidtech healthtech Technologies: A.I. A.I. - Machine Learning A.I. - Deep Learning | 34 | 10 | 28 | 10 | |
GAOMA Therapeutics Bioactive Lipids: the Future for Breakthrough Therapeutics GAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under-exploited, whereas it plays a key role in many medical conditions. GAOMA has the ambition to tap into the therapeutic potential of lipids. The company’s first drug candidate, GAO-3-02, is a novel patented active ingredient. It aims to address epilepsy and cognitive disorders, by targeting neuroinflammation and brain plasticity. In various preclinical experiments, GAO-3-02 has thus demonstrated its ability to limit seizures, protect and restore cognitive … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 5 | |
Med In Town_Medical Devices 3D Printing Notre ambition : Mettre l'impression 3D au service de l'hôpital de demain ! Med In Town propose une solution unique d'impression 3D industrielle au cœur des établissements de santé, permettant à ces derniers de profiter des dernières innovations, tout en respectant les exigences croissantes des industriels du Dispositif Médical. English below Med In Town offers a unique industrial 3D printing solution at the heart of healthcare establishments, allowing them to benefit from the latest innovations, while respecting the growing demands of medical device manufacturers. Impression 3D, Medical Device, Patient Specific Instrument, Modeles anatomiques, Chirurgie sur-mesure, 3D printing, and SLS Polymère Type: Startup Activities: deeptech healthtech industry 4.0 manufacturing Technologies: 3D Printing | 12 | 4 | 5 | 3 | |
Advanced BioDesign Overcoming Tumor Drug Resistance Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes. Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis. Oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 1 | 4 | 22 | |
ETISENSE Jacketed physiological monitoring for life sciences Etisense, is a Lyon (FR) based MedTech company specialized in non-invasive physiological monitoring. Etisense develops unique instrumentation solutions for pre-clinical research and development. DECRO, (www.etisense.com),our 1st product is now available to help scientists to perform pre-clinical research differently. recherche, R&D pharmaceutique, Instruments connectés, Plateforme d'acquisition de signaux physiologiques, Logiciel, and Electronique embarquée Type: Startup Activities: biotech deeptech manufacturing | 4 | 1 | 3 | 15 | |
MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: Startup Activities: healthtech Technologies: Data Analytics | 36 | 6 | 35 | 8 | |
Manitty Monitor the invisible At Manitty, our mission is clear: we decode the body's language to make it universally understandable, anytime, anywhere and for anyone. Our cutting-edge technology, driven by Artificial Intelligence and miniature sensors, collects and correlates vital physiological and brain data. This empowers us to provide smart and predictive diagnostic solutions. Our innovations find applications in various fields, including surgerical monitoring devices, medical diagnostics, pre-/post-operative monitoring, and animal research. solutions We're changing the way the world sees the human and animal body, making advanced healthcare accessible worldwide. Beyond our core mission, we excel in biotelemetry and biologger design, offering … Type: Startup Activities: healthtech deeptech Technologies: A.I. | 13 | 8 | 6 | 8 | |
Maela Solutions connectées pour la préparation et le suivi des patients à domicile dans le cadre de parcours innovants Maela provides a solution to prepare and a service to follow up with patients who will have a surgery. Our goal is to reduce the time spent at the hospital, to provide some innovative services for the patient as for the health institution while always improving the end user quality of life. Our solution is based on the latest technologies (cloud, connected devices, smartphones & tablets) in order to deliver a quality service that is reliable and fully customizable. Maela is an … Type: Startup Activities: healthtech Technologies: IoT | 15 | 6 | 7 | 28 | |
LYOPHITECH Re-inventing large-scale freeze drying LYOPHITECH has developed and patented a new process called Dynamic Lyophilization, which better preserves fragile or oxidation-sensitive active ingredients. We can assist you in developing this process : 1. Feasibility Testing : Our R&D laboratory evaluates the viability of your process. 2. Industrial Testing : We conduct tests in our workshop. 3. Production Support : Available for your production. Machine Range : o Lyophitech7 : 7 liters o Lyophitech50 : 50 liters o Lyophitech1000 : 1000 liters Feel free to contact us ! 🙂 Freeze Drying, Microbiology, Probiotics, Food industry, lyophilisation, lyophilization, Séchage, and Extraits végétaux | 12 | 10 | 4 | 13 | |
3Deus Dynamics Print the Impossible 3Deus Dynamics a pour ambition de repousser les limites de l’impression 3D grâce à son procédé de fabrication additive en milieu granulaire appelé « Moulage Dynamique ». Cette innovation de rupture, hybride entre l’impression 3D et l’injection/moulage, permet de prendre en charge tous les polymères disponibles sur le marché sans reformulation chimique, sans structure support et sans limite de géométrie. De plus le Moulage Dynamique permet également de fabriquer des matériaux composites et donc d’apporter des propriétés additionnelles aux matériaux. Notre société développe actuellement des solutions pour les matériaux Silicones et s’adresse à tous les principaux marchés … Type: Startup Activities: industry 4.0 manufacturing Technologies: 3D Printing | 28 | 11 | 0 | 25 | |
AIS BIOTECH A nature-inspired solution to trap pathogens @AIS Biotech (with AIS for Anti Infective Sugar) is a French Biotech company based in the @Région Auvergne-Rhône-Alpes, France, incorporated in March 2023 with the objective of developing a new class of sugar-based anti-infective biotherapeutics to fight (re)emerging infectious diseases. Thanks to a Bioengineering plateform based on the expertise of the leading edge academic laboratory @CERMAV (@CNRS, @UGA, Grenoble, France), AIS Biotech aims to develop a pipeline of innovative sugar-based biopharmaceuticals which can prevent or treat infections by mimicking the natural host surface oligosaccharide binding-sites of pathogens. GlycoFlu, our first drug-candidate validated at the … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 18 | 7 | 13 | 5 | |
Oncosema Cancer monitoring made easy 🩸OncosemaTM️ is a purpose-driven company. Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient. 🩸OncosemaTM️ is a deeptech start-up. We operate an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer. 🩸OncosemaTM️ is focused on providing impactful tests for Oncology. ✔️Non-invasive ✔️Sensitive and specific ✔️Easy-to-use OncosemaTM️ is a registred trade mark of Oncocellex. Cancer, Diagnostic, Circulating Tumor Cells, Immunodiagnostic, Liquid Biopsy, Medical research, Patients … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 10 | 4 | 7 | 5 | |
KUSTE BIOPHARMA KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science with the aim of tackling major chronic inflammatory diseases | 1 | 1 | 0 | 1 | |
KCAS Bio - Lyon Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics | 2 | 1 | 2 | 31 | |
EVEON Transforming Patient Experience EVEON aims to become international leader in the automatic preparation and delivery of therapeutic treatments to improve patient quality of life. As a partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation products and services. Forward looking, EVEON places at the heart of its commitments social values of high standards that meet the challenges of personalized and participative medicine. EVEON focuses on business partnerships with a collaborative spirit of transparency and openness. EVEON develops a strategy based on ethical values of performance and adaptability to the needs of its clients. Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 15 | 3 | 14 | 18 | |
CLEAN BIOLOGICS Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance Type: Startup Activities: deeptech Technologies: Synthetic Biology | 14 | 8 | 11 | 11 | |
HuntX Pharma Game-changer therapies for incurable axonal transport defects HuntX Pharma has been incorporated in december 2022 with the objective of being Pionneer and Leader in addressing new therapeutical targets to fight axonal transport defect related diseases with Huntington disease as a first indication. #HuntXPharma Type: Startup Activities: transporttech deeptech | 17 | 9 | 7 | 8 | |
ADMIR Analysis With our active Digital Multispectral InfraRed, the bio-analysis gets faster. ADMIR is a deep tech start-up related to biomedical applications developing and manufacturing a diagnostic aid instrument with its mid-infrared spectroscopic imaging system and its machine learning software suite. The system provides infrared spectral fingerprints for each pixel of the sample image, revealing its biochemical content in less than 1 min. ADMIR instrument is a tool for massive analysis to accelerate and secure the diagnosis as well as a great research tool. It opens a new route toward tissue or cell analysis for cancer diagnosis or further biomedical applications offering … Type: Startup Activities: deeptech manufacturing Technologies: A.I. A.I. - Machine Learning A.I. - Deep Learning | 3 | 3 | 0 | 10 | |
CYNBIOSE Exploring together! We support biopharmaceutical research with translational preclinical models. CYNBIOSE is France-based non-clinical research organization. Preclinical CRO, Pharmacokinetics, POC, Efficacy, Immunotherapies, Drug, Early tox, CNS, Infectious diseases, Respiratory diseases, Non clinical, CRO, PK, PD, and TK Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 3 | 5 | 20 | |
Pelican Health Empowering the Health Microbiome Movement The gut microbiome (i.e: the microorganisms present in our intestine) plays a major role in maintaining our health. In case of dysfunction, the microbiome is linked to a large number of inflammatory, metabolic, and neurological diseases. The study of the microbiome opens many perspectives for tomorrow’s medicine. Pelican Health offers a solution enabling multiple sampling of the microbiome in-situ with a single oral administration, in a reliable, precise, simple to administer and non-invasive manner. | 18 | 7 | 6 | 16 | |
Xegen Biostatistics & Bioinformatics company specialized in Next Generation Sequecing data analysis Xegen is a bioinformatics company specialized in Next Generation Sequencing (NGS) data analysis. We provide support for our customers or partners in their NGS data processing issues, through specific, automated, high added value bioinformatics analyzes. Xegen is developing Polypheme a bioinformatics suite dedicated to complex genes analysis (polymorphisms detection or allelic types). Polypheme analysis includes in particular HLA Typing, classic (HLA-A, -B, -C, DRB1, DQB1) and not classic genes (HLA-E, -F, -G, -H). Polypheme is also used to discover new alleles. Bioinformatics, Genomics, Typing, HLA, Diagnostics, NGS data analysis, … Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 9 | 0 | 9 | 3 | |
FABULOUS - 3D PRINTING Innovative 3d printing Materials for industrial applications FABULOUS, expert company in polymeric 3D printing materials, brings innovation to a market now focused on production. FABULOUS is a French company, with European influence and with an international ambition. We are revolutionizing the 3D printing industry with materials that meet the application needs of end users. -> Independant 3d printing materials innovator -> Industrial 3d printing Tech center Impression 3D, fabrication numérique, Conseil, fablab, conception 3D, conseil ingénierie, matériaux impression 3D, fabrication additive, direction artistique 3D, modélisation 3D, communication, objets connectés, 3dprinting, and materials Type: Startup Activities: industry 4.0 Technologies: 3D Printing New Materials | 13 | 1 | 7 | 3 |